Estrella Immunopharma, INC. (ESLAW) — S-1 Filings
All S-1 filings from Estrella Immunopharma, INC.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.
S-1 Filings (1)
-
Estrella Immunopharma Registers 2.5M Shares for Resale Amid Rising Losses
— Dec 22, 2025 Risk: high
Estrella Immunopharma, Inc. (ESLAW) is a clinical-stage biopharmaceutical company focused on T-cell therapies for cancer and autoimmune diseases. The company re
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX